Peritoneal Cancer
A Phase 2 Study of Relacorilant in Combination with Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer (BELLA)(CORT125134-557)
- Details
ClinicalTrials.gov ID:
NCT06906341
Diagnosis Type:
NA
USOR Number:
- Address
,
P: